Nuvalent: Structure-Based Drugs To Inhibit Kinase Targets
marchmeena29/iStock via Getty Images
About
Source: Company website
Nuvalent, Inc. (NUVL) is a Cambridge, MA based preclinical-stage biopharmaceutical company developing drug candidates to precisely inhibit clinically proven kinase targets utilizing their…
